| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $147.6M | 12,480,000 | 55.2% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $21.9M | 1,860,371 | 8.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $21.2M | 307,167 | 7.9% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $10.7M | 878,897 | 4.0% |
| Eyepoint Pharmaceuticals(EYPT) | COM NEW | 30233G209 | $10.5M | 1,410,331 | 3.9% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $8.4M | 446,296 | 3.1% |
| Intra-Cellular Therapies Inc.(ITCIEUR) | COM | 46116X101 | $6.0M | 71,990 | 2.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $5.0M | 224,038 | 1.9% |
| Geron Corporation(GERN) | COM | 374163103 | $4.7M | 1,321,268 | 1.7% |
| Ocular Therapeutix, Inc.(OCUL) | COM | 67576A100 | $4.0M | 470,919 | 1.5% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $4.0M | 121,732 | 1.5% |
| Pharvaris N V(PHVS) | COM | N69605108 | $4.0M | 207,603 | 1.5% |
| Disc Medicine, Inc.(IRON) | COM | 254604101 | $3.6M | 56,400 | 1.3% |
| Springworks Therapeutics, Inc. | COM | 85205L107 | $3.4M | 93,137 | 1.3% |
| Allogene Therapeutics, Inc.(ALLO) | COM | 019770106 | $3.2M | 1,489,909 | 1.2% |
| Mirum Pharmaceuticals, Inc.(MIRM) | COM | 604749101 | $2.7M | 64,900 | 1.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $2.5M | 215,981 | 0.9% |
| Arvinas, Inc.(ARVN) | COM | 04335A105 | $1.7M | 86,627 | 0.6% |
| Scholar Rock Holding Corporation(SRRK) | COM | 80706P103 | $1.4M | 32,000 | 0.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $939.2K | 105,057 | 0.4% |